A prospective study of thimerosal-containing Rho(D)-immune globulin administration as a risk factor for autistic disorders

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 20, Issue 5, 2007, Pages 385-390

  Geier, David A ^a   Geier, Mark R ^b,c  

^a Institute of Chronic Illnesses Inc   (United States)

^b Genetic Centers of America   (United States)

^c NONE   (United States)

Author keywords

Developmental delay; Ethylmercury; Rhogam; Thimerosal; Thiomersal

Indexed keywords

MERCURY; RHESUS D ANTIBODY; THIOMERSAL;

ADOLESCENT; ADULT; ARTICLE; AUTISM; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

AUTISTIC DISORDER; FEMALE; HUMANS; MALE; ODDS RATIO; PREGNANCY; PROSPECTIVE STUDIES; RH-HR BLOOD-GROUP SYSTEM; RHO(D) IMMUNE GLOBULIN; RISK FACTORS; THIMEROSAL;

EID: 34547670583     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050701228057     Document Type: Article

References (47)

1. Eigsti IM, Shapiro T. A systems neuroscience approach to autism: Biological, cognitive, and clinical perspectives. Ment Retard Dev Disabil Res Rev 2003;9:205-215.
2. Werner E, Dawson G. Validation of the phenomenon of autistic regression using home videotapes. Arch Gen Psychiatry 2005;62:889-895.
3. Beversdorf DQ, Manning SE, Hillier A, Anderson SL, Nordgren RE, Walters SE, Nagaraja HN, Colley WC, Gaelic SE, Bauman ML. Timing of prenatal stressors and autism. J Autism Dev Disord 2005;35:471-478.
4. Bernard S, Enayati A, Redwood L, Roger H, Binstock T. Autism: A novel form of mercury poisoning. Med Hypotheses 2001;56:462-471.
5. Bernard S, Enayati A, Roger H, Binstock T, Redwood L. The role of mercury in the pathogenesis of autism. Mol Psychiatry 2002;7(Suppl 2):S42-43.
6. Blaxill MF, Redwood L, Bernard S. Thimerosal and autism? A plausible hypothesis that should not be dismissed. Med Hypotheses 2004;62:788-794.
7. Redwood L, Bernard S, Brown D. Predicted mercury concentrations in hair from infant immunizations: Cause for concern. Neurotoxicology 2001;22:691-697.
8. American College of Obstetricians and Gynecologists. Current uses of Rho immune globulin and detection of antibodies. ACOG Tech Bull 1976;35.
9. American College of Obstetricians and Gynecologists. The selective use of Rho(D) immune globulin (RhIG). ACOG Tech Bull 1981;61.
10. Pollack W. Rh hemolytic disease of the newborn: Its cause and prevention. Prog Clin Biol Res 1981;70:185-203.
11. Bowman JM, Chown B, Lewis M, Pollock JM. Rh isoimmunization during pregnancy: Antenatal prophylaxis. Can Med Assoc J 1978;118:623-627.
12. Bowman JM, Pollock JM. Antenatal prophylaxis of Rho isoimmunization: 28-weeks'-gestation service program. Can Med Assoc J 1978;118:627-630.
13. American College of Obstetricians and Gynecologists. Prevention of D isoimmunization. ACOG Tech Bull 1990;147.
14. Lurie S, Eliezer E, Piper I, Woliovitch I. Is antibody screening in Rh (D)-positive pregnant women necessary? J Matern Fetal Neonatal Med 2003;14:404-406.
15. Holmes AS, Blaxill MF, Haley BE. Reduced levels of mercury in first baby haircuts of autistic children. Int J Toxicol 2003;22:277-285.
16. Mutter J, Naumann J, Schneider R, Walach H, Haley B. Mercury and autism: Accelerating evidence? Neuro Endocrinol Lett 2005;26:439-446.
17. Lathe R. Autism, brain, and environment. Philadelphia, PA: Jessica Kingsley Publishers; 2006.
18. Geier DA, Geier MR. A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders. J Toxicol Environ Health A 2007;70:837-851.
19. Faustman EM, Silbernagel SM, Fenske RA, Burbacher T, Ponce RA. Mechanisms underlying children's susceptibility to environmental toxicants. Environ Health Perspect 2000;108(Suppl 1):13-21.
20. Geier DA, Geier MR. A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders. Horm Res 2006;66:182-188.
21. Amin-Zaki L, Majeed MA, Greenwood MR, Elhassani SB, Clarkson TW, Doherty RA. Methylmercury poisoning in the Iraqi suckling infant: A longitudinal study over five years. J Appl Toxicol 1981;1:210-214.
22. Counter SA, Buchanan LH, Ortega F, Laurell G. Elevated blood mercury and neuro-otological observations in children of the Ecuadorian gold mines. J Toxicol Environ Health 2002;65:149-163.
23. Windham GC, Zhang L, Gunier R, Croen LA, Grether JK. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco Bay area. Environ Health Perspect 2006;114:1438-1444.
24. Palmer RF, Blanchard S, Stein Z, Mandell D, Miller C. Environmental mercury release, special education rates, and autism disorder: An ecological study of Texas. Health Place 2006;12:203-209.
25. Blair AM, Clark B, Clarke AJ, Wood P. Tissue concentrations of mercury after chronic dosing of squirrel monkeys with thiomersal. Toxicology 1975;3:171-176.
26. Burbacher TM, Shen DD, Liberato N, Grant KS, Cernichiari E, Clarkson TW. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect 2005;113:1015-1021.
27. Gasset AR, Itoi M, Ishii Y, Ramer RM. Teratogenicities of ophthalmic drugs II. Teratogenicities and tissue accumulation of thimerosal. Arch Ophthalmol 1975;93:52-55.
28. Slikker W Jr. Developmental neurotoxicology of therapeutics: Survey of novel recent findings. Neurotoxicology 2000;21:250.
29. Fagan DG, Pritchard JS, Clarkson TW, Greenwood MR. Organ mercury levels in infants with omphaloceles treated with organic mercurial antiseptic. Arch Dis Child 1977;52:962-964.
30. Leonard A, Jacquet P, Lauwerys RR. Mutagenicity and teratogenicity of mercury compounds. Mutat Res 1983; 114:1-18.
31. 203Hg labeled mercury compounds in adult and pregnant mice determined by whole-body autoradiography. Radioisotopes 1967;16:440-448.
32. Digar A, Sensharma GC, Samal SN. Lethality and teratogenicity of organic mercury (thimerosal) on the chick embryo. J Anat Soc India 1987;36:153-159.
33. Itoi M, Ishii Y, Kaneko N. Teratogenicities of antiviral ophthalmics on experimental animals. Jpn J Clin Ophthal 1972;26:631-640.
34. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group, Inc; 1977.
35. Hornig M, Chian D, Lipkin WI. Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol Psychiatry 2004;9:833-845.
36. Haley BE. Mercury toxicity: Genetic susceptibility and synergistic effects. Med Ver 2005;2:535-542.
37. Brown LE, Yel L. Thimerosal induces programmed cell death of neuronal cells via changes in the mitochondrial environment. UCI Undergrad Res J 2003;6:7-14.
38. Brunner M, Albertini S, Wurgler FE. Effects of 10 known or suspected spindle poisons in the in vitro porcine brain tubulin assembly assay. Mutagenesis 1991;6:65-70.
39. Humphrey ML, Cole MP, Pendergrass JC, Kiningham KK. Mitochondrial mediated thimerosal-induced apoptosis in a human neuroblastoma cell line (SK-N-SH). Neurotoxicology 2005;26:407-416.
40. Baskin DS, Ngo H, Didenko VV. Thimerosal induces DNA breaks, caspase-3 activation, membrane damage, and cell death in cultured human neurons and fibroblasts. Toxicol Sci 2003;74:361-368.
41. James SJ, Slikker W 3rd, Melnyk S, New E, Pogribna M, Jernigan S. Thimerosal neurotoxicity is associated with glutathione depletion: Protection with glutathione precursors. Neurotoxicology 2005;26:1-8.
42. Parry JM. An evaluation of the use of in vitro tubulin polymerisation, fungal and wheat assays to detect the activity of potential chemical aneugens. Mutation Res 1993;287:23-28.
43. Wallin M, Hartely-Asp B. Effects of potential aneuploidy inducing agents on microtubule assembly in vitro. Mutation Res 1993;287:17-22.
44. Yel L, Brown LE, Su K, Gollapudi S, Gupta S. Thimerosal induces neuronal cell apoptosis by causing cytochrome c and apoptosis-inducing factor release from mitochondria. Int J Mol Med 2005;16:971-977.
45. Mutkus L, Aschner JL, Syversen T, Shanker G, Sonnewald U, Aschner M. In vitro uptake of glutamate in GLAST- and GLT-1-transfected mutant CHO-K1 cells is inhibited by the ethylmercury-containing preservative thimerosal. Biol Trace Elem Res 2005;105:71-86.
46. Parran DK, Barker A, Ehrich M. Effects of thimerosal on NGF signal transduction and cell death in neuroblastoma cells. Toxicol Sci 2005;86:132-140.
47. Waly M, Olteanu H, Banerjee R, Choi SW, Mason JB, Parker BS, Sukumar S, Shim S, Sharma A, Benzecry JM, et al. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: A target for neurodevelopmental toxins and thimerosal. Mol Psychiatry 2004;9:358-370.